Table 2

JACC: Cardiovascular Interventions

Volume 1, Issue 4, August 2008 DOI: 10.1016/j.jcin.2008.05.009

Long-Term Outcomes in High-Risk Symptomatic Patients With Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation

Deborah H. Kwon, Samir R. Kapadia, E. Murat Tuzcu, Carmel M. Halley, Eiran Z. Gorodeski, Ronan J. Curtin, Maran Thamilarasan, Nicholas G. Smedira, Bruce W. Lytle, Harry M. Lever and Milind Y. Desai

Table 2

Description of Alcohol Septal Ablation Patients Who Died During Follow-Up

Deceased Patient	Age at Procedure (yrs)	Reason for Referral to Alcohol Septal Ablation	Age at Death (yrs)	Cause of Death
1	82	Old age	85	Respiratory failure
2	77	Old age	84	Unknown
3	83	Old age	84	Unknown
4	63	History of multiple valve surgeries	70	Liver failure
5	82	Old age	88	Unknown
6	83	Old age	84	Cardiac arrest
7	78	Old age	81	Unknown
8	69	History of recurrent venous thrombosis	74	Unknown
9	60	Severe lung disease	62	Unknown
10	65	Significant psychiatric problems	71	Pneumonia
11	71	Old age plus active cholecystitis	78	Unknown
12	66	Cirrhosis of liver	69	Cirrhosis of liver
13	46	Severe renal failure	46	Renal Failure

User menu

Long-Term Outcomes in High-Risk Symptomatic Patients With Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation

Table 2

JACC: Cardiovascular Interventions

JACC Journals

General Information

American College of Cardiology